These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31909680)

  • 1. Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease.
    de Faria SM; de Morais Fabrício D; Tumas V; Castro PC; Ponti MA; Hallak JE; Zuardi AW; Crippa JAS; Chagas MHN
    J Psychopharmacol; 2020 Feb; 34(2):189-196. PubMed ID: 31909680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
    Bergamaschi MM; Queiroz RH; Chagas MH; de Oliveira DC; De Martinis BS; Kapczinski F; Quevedo J; Roesler R; Schröder N; Nardi AE; Martín-Santos R; Hallak JE; Zuardi AW; Crippa JA
    Neuropsychopharmacology; 2011 May; 36(6):1219-26. PubMed ID: 21307846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test.
    Linares IM; Zuardi AW; Pereira LC; Queiroz RH; Mechoulam R; Guimarães FS; Crippa JA
    Braz J Psychiatry; 2019; 41(1):9-14. PubMed ID: 30328956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.
    Hurd YL; Spriggs S; Alishayev J; Winkel G; Gurgov K; Kudrich C; Oprescu AM; Salsitz E
    Am J Psychiatry; 2019 Nov; 176(11):911-922. PubMed ID: 31109198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder.
    Bolsoni LM; Crippa JAS; Hallak JEC; Guimarães FS; Zuardi AW
    Psychopharmacology (Berl); 2022 May; 239(5):1499-1507. PubMed ID: 35029706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study.
    Spinella TC; Stewart SH; Naugler J; Yakovenko I; Barrett SP
    Psychopharmacology (Berl); 2021 Jul; 238(7):1965-1977. PubMed ID: 33813611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life.
    Zuardi AW; Rodrigues NP; Silva AL; Bernardo SA; Hallak JEC; Guimarães FS; Crippa JAS
    Front Pharmacol; 2017; 8():259. PubMed ID: 28553229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ipsapirone and cannabidiol on human experimental anxiety.
    Zuardi AW; Cosme RA; Graeff FG; Guimarães FS
    J Psychopharmacol; 1993 Jan; 7(1 Suppl):82-8. PubMed ID: 22290374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis.
    Appiah-Kusi E; Petros N; Wilson R; Colizzi M; Bossong MG; Valmaggia L; Mondelli V; McGuire P; Bhattacharyya S
    Psychopharmacology (Berl); 2020 Apr; 237(4):1121-1130. PubMed ID: 31915861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human experimental anxiety: actual public speaking induces more intense physiological responses than simulated public speaking.
    Zuardi AW; Crippa JA; Hallak JE; Gorayeb R
    Braz J Psychiatry; 2013; 35(3):248-53. PubMed ID: 24142085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single oral dose of cannabidiol did not reduce upper limb tremor in patients with essential tremor.
    Santos de Alencar S; Crippa JAS; Brito MCM; Pimentel ÂV; Cecilio Hallak JE; Tumas V
    Parkinsonism Relat Disord; 2021 Feb; 83():37-40. PubMed ID: 33465546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial.
    Gournay LR; Ferretti ML; Bilsky S; Vance E; Nguyen AM; Mann E; Williams P; Leen-Feldner EW
    Psychopharmacology (Berl); 2023 Oct; 240(10):2147-2161. PubMed ID: 37552290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial.
    Chagas MH; Zuardi AW; Tumas V; Pena-Pereira MA; Sobreira ET; Bergamaschi MM; dos Santos AC; Teixeira AL; Hallak JE; Crippa JA
    J Psychopharmacol; 2014 Nov; 28(11):1088-98. PubMed ID: 25237116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
    Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
    Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Double-Blind, Randomized, Placebo-Controlled Test of the Effects of Cannabidiol on Experiences of Test Anxiety Among College Students.
    Stanley TB; Ferretti ML; Bonn-Miller MO; Irons JG
    Cannabis Cannabinoid Res; 2023 Dec; 8(6):1090-1099. PubMed ID: 35861792
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol for the treatment of psychosis in Parkinson's disease.
    Zuardi AW; Crippa JA; Hallak JE; Pinto JP; Chagas MH; Rodrigues GG; Dursun SM; Tumas V
    J Psychopharmacol; 2009 Nov; 23(8):979-83. PubMed ID: 18801821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological bases for a possible effect of cannabidiol in Parkinson's disease.
    Ferreira-Junior NC; Campos AC; Guimarães FS; Del-Bel E; Zimmermann PMDR; Brum Junior L; Hallak JE; Crippa JA; Zuardi AW
    Braz J Psychiatry; 2020 Apr; 42(2):218-224. PubMed ID: 31314869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study.
    Bloomfield MAP; Yamamori Y; Hindocha C; Jones APM; Yim JLL; Walker HR; Statton B; Wall MB; Lees RH; Howes OD; Curran VH; Roiser JP; Freeman TP
    Psychopharmacology (Berl); 2022 May; 239(5):1539-1549. PubMed ID: 35445839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
    Elsaid S; Kloiber S; Le Foll B
    Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.